Amgen's Obesity Candidate MariTide Must Mitigate Tolerability Issues to Compete with Blockbuster Tirzepatide, Truist Says

Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
295.06 USD | -0.54% |
|
-4.14% | +13.21% |